ARCHIVES

Drug Development Gets Extra $500,000

This article is from The Cancer Letter archive.

Vol. 03 No. 46 | November 18, 1977

Download PDF Visit The Full Archive

Related Articles

ASCO, NCCS Call For Oncology Center

September 13, 2002

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

May 30, 1980

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

New Guidelines Developed For Cancer Control Granters For Community Outreach

June 4, 1976

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986